WO2014004177A3 - Application topique de 1-hydroxyl-3,5-bis(4'-hydroxylstyryl)benzène - Google Patents

Application topique de 1-hydroxyl-3,5-bis(4'-hydroxylstyryl)benzène Download PDF

Info

Publication number
WO2014004177A3
WO2014004177A3 PCT/US2013/046354 US2013046354W WO2014004177A3 WO 2014004177 A3 WO2014004177 A3 WO 2014004177A3 US 2013046354 W US2013046354 W US 2013046354W WO 2014004177 A3 WO2014004177 A3 WO 2014004177A3
Authority
WO
WIPO (PCT)
Prior art keywords
hydroxyl
benzene
bis
styryl
topical application
Prior art date
Application number
PCT/US2013/046354
Other languages
English (en)
Other versions
WO2014004177A2 (fr
Inventor
Simarna Kaur
Michael D. Southall
Robert A. Zivin
Chong Jin Loy
Samantha TUCKER SAMARAS
Original Assignee
Johnson & Johnson Consumer Companies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/537,959 external-priority patent/US8846013B2/en
Priority claimed from US13/538,017 external-priority patent/US20140005275A1/en
Priority claimed from US13/538,054 external-priority patent/US8758731B2/en
Priority to BR112014032739A priority Critical patent/BR112014032739A2/pt
Priority to CA2877471A priority patent/CA2877471A1/fr
Priority to KR20157002114A priority patent/KR20150023891A/ko
Application filed by Johnson & Johnson Consumer Companies, Inc. filed Critical Johnson & Johnson Consumer Companies, Inc.
Priority to EP13733189.8A priority patent/EP2866779A2/fr
Priority to AU2013280916A priority patent/AU2013280916B2/en
Priority to CN201380035518.2A priority patent/CN104411288B/zh
Priority to RU2015102833A priority patent/RU2648763C2/ru
Publication of WO2014004177A2 publication Critical patent/WO2014004177A2/fr
Publication of WO2014004177A3 publication Critical patent/WO2014004177A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Abstract

La présente invention concerne des compositions de 1-hydroxyl-3,5-bis(4'-hydroxylstyryl)benzène ou un sel acceptable au niveau cosmétique de celles-ci, et des procédés de traitement de la peau humaine utilisant lesdites compositions.
PCT/US2013/046354 2012-06-29 2013-06-18 Application topique de 1-hydroxyl-3,5-bis(4'-hydroxylstyryl)benzène WO2014004177A2 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
RU2015102833A RU2648763C2 (ru) 2012-06-29 2013-06-18 Местное применение 1-гидрокси 3,5-бис(4′гидроксистирил)бензола
CN201380035518.2A CN104411288B (zh) 2012-06-29 2013-06-18 1‑羟基3,5‑双(4’羟基苯乙烯基)苯的局部施用
AU2013280916A AU2013280916B2 (en) 2012-06-29 2013-06-18 Topical application of 1-hydroxyl 3,5-bis(4'hydroxyl styryl)benzene
CA2877471A CA2877471A1 (fr) 2012-06-29 2013-06-18 Application topique de 1-hydroxyl-3,5-bis(4'-hydroxylstyryl)benzene
KR20157002114A KR20150023891A (ko) 2012-06-29 2013-06-18 1-하이드록실 3,5-비스(4''하이드록실 스티릴)벤젠의 국소 적용
BR112014032739A BR112014032739A2 (pt) 2012-06-29 2013-06-18 uso tópico de 1-hidroxila 3,5-bis(4'hidroxila estirila)benzeno
EP13733189.8A EP2866779A2 (fr) 2012-06-29 2013-06-18 Application topique de 1-hydroxyl-3,5-bis(4'-hydroxylstyryl)benzène

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US13/537,959 US8846013B2 (en) 2012-06-29 2012-06-29 Topical application of 1-hydroxyl-3,5-BIS(4′hydroxy styryl)benzene
US13/538,054 US8758731B2 (en) 2012-06-29 2012-06-29 Skin lightening by topical application of 1-hydroxyl 3,5-bis(4′hydroxyl styryl)benzene
US13/538,017 2012-06-29
US13/538,017 US20140005275A1 (en) 2012-06-29 2012-06-29 Topical application of 1-hydroxyl 3,5-bis(4'hydroxyl styryl)benzene
US13/538,054 2012-06-29
US13/537,959 2012-06-29

Publications (2)

Publication Number Publication Date
WO2014004177A2 WO2014004177A2 (fr) 2014-01-03
WO2014004177A3 true WO2014004177A3 (fr) 2014-08-07

Family

ID=48741561

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2013/046354 WO2014004177A2 (fr) 2012-06-29 2013-06-18 Application topique de 1-hydroxyl-3,5-bis(4'-hydroxylstyryl)benzène

Country Status (8)

Country Link
EP (1) EP2866779A2 (fr)
KR (1) KR20150023891A (fr)
CN (1) CN104411288B (fr)
AU (1) AU2013280916B2 (fr)
BR (1) BR112014032739A2 (fr)
CA (1) CA2877471A1 (fr)
RU (1) RU2648763C2 (fr)
WO (1) WO2014004177A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104840399B (zh) * 2015-05-18 2018-10-23 中山安理汇日用品有限公司 具备自防腐特性的紧肤霜配方

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113388A1 (en) * 2001-12-13 2003-06-19 Dung Phan Methods of treatment for skin disorders using turmeric extract and a hydroxy acid
WO2004031122A1 (fr) * 2002-10-01 2004-04-15 Dr. André Rieks - Labor Für Enzymtechnologie Gmbh Nouveaux derives de curcumine/tetrahydrocurcumine destines a etre utilises dans des produits cosmetiques et pharmaceutiques ainsi que dans l'alimentation
US20100190803A1 (en) * 2009-01-23 2010-07-29 Korea Institute Of Science And Technology Bis(styryl)pyrimidine or bis(styryl)benzene compounds, pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition for prevention or treatment of diseases featuring amyloids comprising the same as an active ingredient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2383341C2 (ru) * 2007-11-29 2010-03-10 Ольга Викторовна Кухарева Способ омоложения кожи
US7745670B2 (en) 2008-06-27 2010-06-29 Codman & Shurtleff, Inc. Curcumin-Resveratrol hybrid molecule
US8318217B2 (en) * 2009-10-02 2012-11-27 Johnson & Johnson Consumer Companies, Inc. Compositions comprising an anti-inflammatory blend

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113388A1 (en) * 2001-12-13 2003-06-19 Dung Phan Methods of treatment for skin disorders using turmeric extract and a hydroxy acid
WO2004031122A1 (fr) * 2002-10-01 2004-04-15 Dr. André Rieks - Labor Für Enzymtechnologie Gmbh Nouveaux derives de curcumine/tetrahydrocurcumine destines a etre utilises dans des produits cosmetiques et pharmaceutiques ainsi que dans l'alimentation
US20100190803A1 (en) * 2009-01-23 2010-07-29 Korea Institute Of Science And Technology Bis(styryl)pyrimidine or bis(styryl)benzene compounds, pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition for prevention or treatment of diseases featuring amyloids comprising the same as an active ingredient

Also Published As

Publication number Publication date
CN104411288A (zh) 2015-03-11
KR20150023891A (ko) 2015-03-05
AU2013280916B2 (en) 2018-03-15
CA2877471A1 (fr) 2014-01-03
WO2014004177A2 (fr) 2014-01-03
RU2015102833A (ru) 2016-08-20
CN104411288B (zh) 2017-10-17
AU2013280916A1 (en) 2015-01-22
RU2648763C2 (ru) 2018-03-28
EP2866779A2 (fr) 2015-05-06
BR112014032739A2 (pt) 2017-06-27

Similar Documents

Publication Publication Date Title
WO2012116081A3 (fr) Procédés d'identification d'agents cosmétiques pour des compositions de soins de la peau
BR112013015855A2 (pt) composto, uso de um composto, métodos de prevenção, tratamento, melhora ou profilaxia de distúrbios fisiológicos ou doenças, e de tratamento ou melhora de indicações cosméticas, e, composição farmacêutica.
WO2011007183A3 (fr) Compositions de soins de la peau
BR112015010772A2 (pt) composição de enxágue tópica, uso de uma composição e método para tratar ou melhorar a pele de um indivíduo contra a acne
WO2014108846A3 (fr) Composition cosmétique apaisante basée sur de l'acide salicylique
WO2011122869A3 (fr) Composition cosmétique comprenant du coumestrol ou un extrait de fèves contenant du coumestrol, pour les soins de la peau
WO2015031971A8 (fr) Composition comprenant un extrait de guaçatonga et un extrait d'aroeira, son utilisation, et méthode de prévention et/ou de traitement des signes provoqués par le viellissement cutané
ZA201400357B (en) Alkylamidothiazoles, cosmetic or dermatological preparations containing said alkylamidothiazoles, and use thereof to combat or prevent undesired pigmentation of the skin
WO2012050745A3 (fr) Compositions contenant du zinc pca et un extrait d'anogeissus
WO2012116990A3 (fr) Nouvelle utilisation
WO2013184908A3 (fr) Systèmes et procédés d'identification d'agents cosmétiques pour des compositions de soins de cheveux/cuir chevelu
EP2676703A3 (fr) Procédés d'éclaircissement de la peau
WO2013174774A3 (fr) Compositions cosmétiques comprenant des magnétosomes et leurs utilisations
BR112013015877A2 (pt) composto, uso de um composto, métodos de prevenção. tratamento, melhora ou profilaxia de distúrbios fisiológicos ou doenças, e de tratamento ou melhora de indicações cosméticas, e, composição farmacêutica.
WO2012076109A3 (fr) 2-pyrones
BR112015010819A8 (pt) ''composição de lavagem tópica, uso de composição e método para tratar ou melhorar a pele de indivíduos com acne''
MX2016015256A (es) Composicion de aclaramiento topica y metodos de uso de la misma.
EP4241855A3 (fr) Activite antibacterienne de l'association d'un oligogalactosaccharide et de xylitol dans les traitements dermatologiques.
WO2014082794A3 (fr) Lotion capillaire triphasée
WO2012024394A3 (fr) Compositions comprenant de la paulownine et/ou des extraits de paulownia et utilisations de celles-ci
WO2013190548A3 (fr) Compositions topiques pour le traitement de maladies inflammatoires chroniques de la peau
WO2014102483A3 (fr) Composition cosmetique ou dermatologique a base d'extraits d'iris et son utilisation
WO2011107866A3 (fr) Dérivés silyliques de polysaccharides
EP4289412A3 (fr) Formulations cutanées topiques
WO2014004177A3 (fr) Application topique de 1-hydroxyl-3,5-bis(4'-hydroxylstyryl)benzène

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2877471

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2013280916

Country of ref document: AU

Date of ref document: 20130618

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 20157002114

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2015102833

Country of ref document: RU

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2013733189

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13733189

Country of ref document: EP

Kind code of ref document: A2

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112014032739

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112014032739

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20141229